Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD)

Clinical trial NCT00759876 · TERMINATED

Trial details

NCT number: NCT00759876
Sponsor: PTC Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2008-08-13
Primary completion: 2010-05-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.